In VitroAntibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria

In VitroActivity of AZD0914, a Novel DNA Gyrase Inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae

(2014) Stephan A. Kohlhoff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage

(2014) Flávia Rossi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain

(2012) J. Camara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus

(2010) Esteban Nannini et al.   CURRENT OPINION IN PHARMACOLOGY

Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit

(2010) Miguel Sánchez García   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION